Elidel Facts:

On January 19, 2006 the FDA required black box labeling for two topical eczema drugs, Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus). The labeling was be updated with a boxed warning about the possible risk of lymph node or skin cancer. The FDA action in January 2006 followed an agency advisory committee recommendation in February 2005 that Elidel cream and Protopic ointment carry the cancer risk label warnings.

Suppression of the immune system is believed by some health practitioners to have possible adverse health effects. In addition to cancer risk, there are other potential side effects with this class of drugs. Adverse reactions including severe flushing, photosensitive reactivity and possible drug interaction in patients who consume even small amounts of alcohol.

Usage:

Elidel is an immunomodulating (immune suppressing) agent used in the treatment of atopic dermatitis (eczema). It is currently available as a topical cream, once marketed by Novartis, (however Galderma will be promoting the molecule in Canada in early 2007) under the trade name Elidel.

Litigation:

The drug companies involved now appear to be backtracking and contradicting earlier claims about the safety of using Elidel or Protopic, which were once touted as safer alternatives to steroid creams.

If you or a loved one have experienced adverse effects as a result of Elidel, please submit the contact form at right and an experienced DrugSettlement.com attorney or representative will call you for a free and confidential evaluation of your case.

If you or a member of your family may have been injured as a result of a pharmaceutical drug, please contact the defective drug lawyers at the Law Office of Nix and McIntyre.

We serve clients nationwide, in Alabama (Montgomery), Alaska (Juneau), Arizona (Phoenix), Arkansas (Little Rock), California (Los Angeles, San Diego, San Francisco), Colorado (Denver), Connecticut (Hartford), Delaware (Dover), Florida (Jacksonville, Miami), Georgia (Atlanta), Hawaii (Honolulu), Idaho (Boise), Illinois (Chicago), Indiana (Indianapolis), Iowa (Des Moines), Kansas (Topeka), Kentucky (Frankfort), Louisiana (New Orleans), Maine (Augusta), Maryland (Baltimore), Massachusetts (Boston), Michigan (Detroit) Minnesota (Minneapolis), Mississippi (Jackson), Missouri (St. Louis, Kansas City), Montana (Helena), Nebraska (Lincoln), Nevada (Las Vegas), New Hampshire (Concord), New Jersey (Trenton), New Mexico (Santa Fe), New York (New York City), North Carolina (Charlotte), North Dakota (Bismarck), Ohio (Columbus, Cleveland), Oklahoma (Oklahoma City), Oregon (Portland), Pennsylvania (Philadelphia), Rhode Island (Providence), South Carolina (Columbia), South Dakota (Pierre), Tennessee (Memphis, Nashville), Texas (Dallas, Houston) Utah (Salt Lake City), Vermont (Montpelier), Washington (Seattle), Washington D.C., West Virginia (Charleston), Wisconsin (Madison) and Wyoming (Cheyenne) and their surrounding areas.